Improving radiotherapy in immunosuppressive microenvironments by targeting complement receptor C5aR1.

Beach C., MacLean D., Majorova D., Melemenidis S., Nambiar DK., Kim RK., Valbuena GN., Guglietta S., Krieg C., Darvish-Damavandi M., Suwa T., Easton A., Hillson LV., McCulloch AK., McMahon RK., Pennel K., Edwards J., O'Cathail SM., Roxburgh CS., Domingo E., Moon EJ., Jiang D., Jiang Y., Zhang Q., Koong AC., Woodruff TM., Graves EE., Maughan T., Buczacki SJ., Stucki M., Le Q-T., Leedham SJ., Giaccia AJ., Olcina MM.

DOI

10.1172/JCI185067

Type

Journal article

Journal

J Clin Invest

Publication Date

15/08/2024

Volume

134

Keywords

Humans, Receptor, Anaphylatoxin C5a, Animals, Mice, Tumor Microenvironment, Neoplasms

Permalink Original publication